Title Details

Home Obi Profile Fees Services News Publications Contact

ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
No-Receipt date	2019-02886 - 30/07/2019
No-Filing date	20190402322 - 30/07/2019
No-Granting date	3100768 - 04/10/2019
No-EPO application date	16725997.7 - 18/05/2016
No-EPO granting date	3298021 - 01/05/2019
Gazette No-Publication date of application	-
Gazette No-Publication date of granted patent	10/2019 - 28/11/2019
Expiration date	19/05/2036
Kind of title	Validation of European Patent
Legal status	VALID
Priorities	US201562163188 P18/05/2015/US
Active Substance of Supplementary Certificates	-

IPC Classification

Ipc Class
A61K 31/661
A61P 35/00
C07F 9/12

Related Documents

Related Titles

Owners

Code	Firstname	Surname	Address	Town	ZIP	Country
1580608		SUMITOMO PHARMA ONCOLOGY, INC.	84 WATERFORD DRIVE MARLBOROUGH,	MA 01752, U.S.A.		UNITED STATES OF AMERICA (USA)

Inventors

Code	Firstname	Surname
2620683		SIDDIQUI-JAIN, ADAM
2620684		BEARSS, DAVID, J.

Representatives

Code	Firstname	Surname	Address	Town	Zip
3464	EFANGELIA	GIAZITZOGLOU "ELENI G. PAPAKONSTANTINOU KAI SYNERGATES, DIKIGORIKI ETAIRIA"	KOUMPARI 2	ATHINA (ATTIKIS)	10674

Contact

Code	Firstname	Surname	Address	Town	Zip	Country
848	EFANGELIA	GIAZITZOGLOU - THOMAIDOU	KOUMPARI 2	ATHINA (ATTIKIS)	10674	GREECE

Owners History

Date	Description	Comments	Data before modification	Data after modification
01/07/2020	Αλλαγή Διεύθυνσης Δικαιούχου (7e800)	Α.Π.5320, ΑΡ.ΥΠ.2879236/5-20, ΔΝΥ758, ΚΩΔ.ΠΛΗΡ.3458. (ΒΕΒΑΙΩΣΗ, βασει κοινοπ. ΕΓΔΕ, αριθμ. 201 608 a/scho/27.9.2019)	1041151 Tolero Pharmaceuticals, Inc. 2975 W. Executive Parkway, Suite 320 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Lehi, UT 84043	1219343 Tolero Pharmaceuticals, Inc. 3900 N Traverse Mountain Blvd., Suite 100 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Lehi, UT 84043, U.S.A.
24/11/2020	Μεταβίβαση (7e802)	ΑΡ.ΠΡ. 13681/10-11-2020, ΑΡ.ΥΠΟΘ. 3784106, ΔΝΥ. 1974, ΚΩΔ.ΠΛ. 3458	1219343 Tolero Pharmaceuticals, Inc. 3900 N Traverse Mountain Blvd., Suite 100 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Lehi, UT 84043, U.S.A.	1275249 Boston Biomedical, Inc. 640 Memorial Drive ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Cambridge, MA 02139
24/11/2020	Αλλαγή Επωνυμίας Δικαιούχου (7e801)	ΑΡ.ΠΡ. 13682/10-11-2020, ΑΡ.ΥΠΟΘ. 3784118, ΔΝΥ. 1975, ΚΩΔ.ΠΛ. 3458	1275249 Boston Biomedical, Inc. 640 Memorial Drive ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Cambridge, MA 02139	1275250 Sumitomo Dainippon Pharma Oncology, Inc. 640 Memorial Drive ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Cambridge, MA 02139
07/10/2022	Αλλαγή Επωνυμίας Δικαιούχου (7e801)	Α.Π.18696, ΑΡ.ΥΠ.4586055, ΔΝΥ.1844, ΚΩΔ.ΠΛΗΡ.3463	1275250 Sumitomo Dainippon Pharma Oncology, Inc. 640 Memorial Drive ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Cambridge, MA 02139	1471643 Sumitomo Pharma Oncology, Inc. 640 Memorial Drive ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Cambridge, MA 02139
19/10/2023	Αλλαγή Έδρας (7e805)	Α.Π.34378, ΑΡ.ΥΠ.4752173/23, ΚΩΔ.ΠΛΗΡ.3463	1471643 Sumitomo Pharma Oncology, Inc. 640 Memorial Drive ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Cambridge, MA 02139	1580608 Sumitomo Pharma Oncology, Inc. 84 Waterford Drive Marlborough, ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ MA 01752, U.S.A.

Title Instruments

Payments history 10 renewals have been done

designed & developed by PROFILE S.A.

Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015

The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).